Cambodia-China International Fertility Center was established with joint authorization from the Ministry of Health and Ministry of Commerce of the Kingdom of Cambodia.

Supported by advanced international technology, modern equipment, and leading fertility specialists, the center has become one of Asia's prominent reproductive medicine centers.

The center has approximately 2,500 square meters of clinical space and a highly experienced team of infertility, embryology, and genetics specialists. Using current international assisted reproductive technologies, it has established leading Asian platforms for assisted reproduction and cytogenetic and molecular genetic diagnosis.

The center has approximately 2,500 square meters of clinical space and an experienced team of infertility, embryology, and genetics specialists. Its leading assisted reproduction, cytogenetic, and molecular genetic diagnostic platforms support IVF services, particularly third-generation IVF using preimplantation genetic screening/diagnosis (PGS/PGD). Current next-generation sequencing (NGS) technology is used to support high IVF success rates.

With a professional team offering 18 years of experience, the center provides IVF diagnosis and treatment through patient-centered, international care processes. Its specialized genetic testing supports healthy pregnancies, with the goal of helping families affected by infertility have children.

Success Rates

Leading specialists and advanced technology 

The center's laboratory uses advanced international instruments and equipment. Its team includes director-level specialists from major fertility centers at Grade III Class A public hospitals in China and embryologists with experience across more than 6,000 laboratory cycles. It uses advanced next-generation sequencing to support IVF success rates.

Safety

Dedicated safety departments and personnel. The reproductive medicine center has supporting departments including internal medicine and an emergency room, along with professional nursing staff experienced in ICU care and trained to manage emergencies and protect patient safety.

Quality Assurance

(1) Professional genetic testing and counseling: preimplantation single-cell sequencing (PGS) can comprehensively assess the structure and number of all 23 chromosome pairs and identify abnormalities in embryonic genetic material. This can reduce miscarriage risk and improve pregnancy rates.

(2) Preimplantation genetic diagnosis (PGD) can identify diseases caused by single-gene defects, such as thalassemia. Testing is currently available for 125 single-gene disorders.

(3) Noninvasive prenatal testing (NIPT) sequences fetal nucleated red blood cells in maternal peripheral blood and can be performed as early as 5 weeks of pregnancy. It is noninvasive and rapid, with reports prepared to international standards for clinical guidance.

(4) A US-trained genetic counselor provides preconception genetic counseling and recommends suitable diagnostic and treatment strategies to support prevention and care.